<DOC>
	<DOCNO>NCT02830841</DOCNO>
	<brief_summary>Remote ischemic preconditioning ( RIPC ) emerge promise therapeutic paradigm combat detrimental impact ischemic reperfusion injury . In liver transplantation , ischemic reperfusion injury severely impact post-surgery liver function patient outcome . This prospective , double blind , randomize clinical trial aim test protective effect RIPC hepatic ischemic reperfusion injury pediatric liver transplantation .</brief_summary>
	<brief_title>Liver Protection RIPC Pediatric Living Donor Liver Transplantation</brief_title>
	<detailed_description>Pediatric liver transplantation remain major therapeutic strategy pediatric biliary atresia patient . With almost 60 year improvements refinement surgical technique perioperative management standard , liver transplantation gain popularity gradually turn curative treatment option patient irrevocable liver failure , childhood acute chronic liver failure , inherit liver disease also biliary atresia . In liver transplantation , hepatic ischemic reperfusion injury ( HIRI ) remain critical clinical issue . Importantly , well know severity HIRI may fundamental impact transplant organ function long term graft survival . Furthermore , pediatric patient venerable less tolerated receive ischemic donor liver due small body weight.Although detrimental impact HIPI graft function long recognize , little progress make attenuate severity HIPI compare cardiac ischemic reperfusion ( IR ) injury . In experimental animal model , remote ischemic preconditioning consistently show beneficial effect . However , protective paradigm yet test liver transplantation patient clinical scenario . Considering grow number pediatric patient undergo liver transplantation possibly underdevelop organ function , investigator seek determine whether remote ischemic preconditioning could ameliorate HIPI improve long term graft/patient survival pediatric liver transplantation patient use double-blind randomized clinical trial .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<criteria>Pediatric patient age 3 month 6 year Scheduled live donor liver transplantation Retransplantation Patients localize systemic infection Patients cormorbid autoimmune disease Peripheral vascular disease Prior history thromboembolic disease Combined liver kidney transplantation Lack inform consent</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>RIPC</keyword>
	<keyword>hepatic ischemic reperfusion injury</keyword>
	<keyword>pediatric living donor liver transplantation</keyword>
</DOC>